Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Robarts Research Institute, |
RCV000408896 | SCV000484803 | likely pathogenic | Hypercholesterolemia, familial, 1 | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001850943 | SCV002236918 | pathogenic | Familial hypercholesterolemia | 2021-11-17 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 369867). This sequence change creates a premature translational stop signal (p.Cys302Serfs*68) in the LDLR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LDLR are known to be pathogenic (PMID: 20809525, 28645073). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with hypercholesterolemia (PMID: 27765764). For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV000408896 | SCV003830896 | likely pathogenic | Hypercholesterolemia, familial, 1 | 2022-02-22 | criteria provided, single submitter | clinical testing |